Immunome, Inc. · NASDAQ:IMNM

Point72 Asset Management, L.P. reported a 5.90% stake in Immunome, Inc. (Schedule 13G)

Event Jan 31, 2025 · Filed Feb 3, 2025

Point72 Asset Management, L.P. reported a 5.90% stake in Immunome, Inc., 4,887,110 shares, as a passive investor on Jan 31, 2025. Filed Feb 3, 2025 (Schedule 13G).

Stake
5.90%
Shares
4,887,110
Intent
Passive
What changed
Crossed above 5%
Filed together
3 holders

The filing in full

HolderStakeShares
Point72 Asset Management, L.P.5.90%4,887,110
Point72 Capital Advisors, Inc.5.90%4,887,110
Steven A. Cohen5.90%4,887,110

Source

View original at SEC

Related